Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction.

Fosshaug LE, Colas RA, Anstensrud AK, Gregersen I, Nymo S, Sagen EL, Michelsen A, Vinge LE, Øie E, Gullestad L, Halvorsen B, Hansen TV, Aukrust P, Dalli J, Yndestad A.

EBioMedicine. 2019 Aug;46:264-273. doi: 10.1016/j.ebiom.2019.07.024. Epub 2019 Jul 22.

2.

Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome.

Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Emdin M.

Eur J Prev Cardiol. 2019 Jun 1:2047487319852809. doi: 10.1177/2047487319852809. [Epub ahead of print]

PMID:
31154828
3.

Investigating the effect of sex and ketosis on weight-loss-induced changes in appetite.

Lyngstad A, Nymo S, Coutinho SR, Rehfeld JF, Truby H, Kulseng B, Martins C.

Am J Clin Nutr. 2019 Jun 1;109(6):1511-1518. doi: 10.1093/ajcn/nqz002.

4.

Electrolyte imbalances in an unselected population in an emergency department: A retrospective cohort study.

Tazmini K, Nymo SH, Louch WE, Ranhoff AH, Øie E.

PLoS One. 2019 Apr 25;14(4):e0215673. doi: 10.1371/journal.pone.0215673. eCollection 2019.

5.

Physiological Predictors of Weight Regain at 1-Year Follow-Up in Weight-Reduced Adults with Obesity.

Nymo S, Coutinho SR, Rehfeld JF, Truby H, Kulseng B, Martins C.

Obesity (Silver Spring). 2019 Jun;27(6):925-931. doi: 10.1002/oby.22476. Epub 2019 Apr 20.

6.

Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study.

Siljan WW, Holter JC, Michelsen AE, Nymo SH, Lauritzen T, Oppen K, Husebye E, Ueland T, Mollnes TE, Aukrust P, Heggelund L.

ERJ Open Res. 2019 Mar 11;5(1). pii: 00014-2019. doi: 10.1183/23120541.00014-2019. eCollection 2019 Feb.

7.

Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4.

Landsem A, Fure H, Krey Ludviksen J, Christiansen D, Lau C, Mathisen M, Bergseth G, Nymo S, Lappegård KT, Woodruff TM, Espevik T, Mollnes TE, Brekke OL.

Clin Exp Immunol. 2019 Apr;196(1):97-110. doi: 10.1111/cei.13240. Epub 2018 Dec 19.

8.

High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.

Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Rocca HB, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Wilson Tang WH, Grodin JL, Passino C, Emdin M.

Int J Cardiol. 2019 Feb 15;277:166-172. doi: 10.1016/j.ijcard.2018.10.079. Epub 2018 Oct 26.

PMID:
30416028
9.

sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.

Emdin M, Aimo A, Vergaro G, Bayes-Genis A, Lupón J, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Gullestad L, Broch K, Ueland T, Nymo SH, Brunner-La Rocca HP, de Boer RA, Gaggin HK, Ripoli A, Passino C, Januzzi JL Jr.

J Am Coll Cardiol. 2018 Nov 6;72(19):2309-2320. doi: 10.1016/j.jacc.2018.08.2165.

PMID:
30384887
10.

Investigation of the long-term sustainability of changes in appetite after weight loss.

Nymo S, Coutinho SR, Eknes PH, Vestbostad I, Rehfeld JF, Truby H, Kulseng B, Martins C.

Int J Obes (Lond). 2018 Aug;42(8):1489-1499. doi: 10.1038/s41366-018-0119-9. Epub 2018 Jun 21.

11.

Timeline of changes in adaptive physiological responses, at the level of energy expenditure, with progressive weight loss.

Nymo S, Coutinho SR, Torgersen LH, Bomo OJ, Haugvaldstad I, Truby H, Kulseng B, Martins C.

Br J Nutr. 2018 Jul;120(2):141-149. doi: 10.1017/S0007114518000922. Epub 2018 May 7.

12.

Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome.

Nymo SH, Hartford M, Ueland T, Yndestad A, Lorentzen E, Truvé K, Karlsson T, Ravn-Fischer A, Aukrust P, Caidahl K.

Int J Cardiol. 2018 Jul 1;262:79-84. doi: 10.1016/j.ijcard.2018.03.028. Epub 2018 Mar 8.

PMID:
29622507
13.

Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia.

Siljan WW, Holter JC, Nymo SH, Husebye E, Ueland T, Skattum L, Bosnes V, Garred P, Frøland SS, Mollnes TE, Aukrust P, Heggelund L.

Open Forum Infect Dis. 2018 Jan 5;5(2):ofy002. doi: 10.1093/ofid/ofy002. eCollection 2018 Feb.

14.

Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.

Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Tang WHW, Grodin J, Passino C, Emdin M.

Circulation. 2018 Jan 16;137(3):286-297. doi: 10.1161/CIRCULATIONAHA.117.031560.

PMID:
29335288
15.

Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia.

Siljan WW, Holter JC, Nymo SH, Husebye E, Ueland T, Aukrust P, Mollnes TE, Heggelund L.

Eur J Clin Invest. 2018 Jan;48(1). doi: 10.1111/eci.12865. Epub 2017 Dec 7.

16.

Timeline of changes in appetite during weight loss with a ketogenic diet.

Nymo S, Coutinho SR, Jørgensen J, Rehfeld JF, Truby H, Kulseng B, Martins C.

Int J Obes (Lond). 2017 Aug;41(8):1224-1231. doi: 10.1038/ijo.2017.96. Epub 2017 Apr 25.

17.

Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure.

Nymo SH, Aukrust P, Kjekshus J, McMurray JJ, Cleland JG, Wikstrand J, Muntendam P, Wienhues-Thelen U, Latini R, Askevold ET, Gravning J, Dahl CP, Broch K, Yndestad A, Gullestad L, Ueland T; CORONA Study Group.

JACC Heart Fail. 2017 Apr;5(4):256-264. doi: 10.1016/j.jchf.2017.01.008.

18.

Properdin binding to complement activating surfaces depends on initial C3b deposition.

Harboe M, Johnson C, Nymo S, Ekholt K, Schjalm C, Lindstad JK, Pharo A, Hellerud BC, Nilsson Ekdahl K, Mollnes TE, Nilsson PH.

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E534-E539. doi: 10.1073/pnas.1612385114. Epub 2017 Jan 9.

19.

Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome.

Siljan WW, Holter JC, Nymo SH, Schjalm C, Müller F, Jenum PA, Husebye E, Ueland T, Aukrust P, Mollnes TE, Heggelund L.

J Infect. 2016 Oct;73(4):383-6. doi: 10.1016/j.jinf.2016.07.011. Epub 2016 Jul 21. No abstract available.

PMID:
27452197
20.

Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).

Arain F, Gullestad L, Nymo S, Kjekshus J, Cleland JG, Michelsen A, McMurray JJ, Wikstrand J, Aukrust P, Ueland T.

Biomarkers. 2017 May - Jun;22(3-4):261-267. doi: 10.1080/1354750X.2016.1204003. Epub 2016 Jul 12.

21.

Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Toll-like Receptor 4-MD2 Complex.

Gustavsen A, Nymo S, Landsem A, Christiansen D, Ryan L, Husebye H, Lau C, Pischke SE, Lambris JD, Espevik T, Mollnes TE.

J Infect Dis. 2016 Jul 1;214(1):140-50. doi: 10.1093/infdis/jiw100. Epub 2016 Mar 14.

22.

Human Endothelial Cell Activation by Escherichia coli and Staphylococcus aureus Is Mediated by TNF and IL-1β Secondarily to Activation of C5 and CD14 in Whole Blood.

Nymo S, Gustavsen A, Nilsson PH, Lau C, Espevik T, Mollnes TE.

J Immunol. 2016 Mar 1;196(5):2293-9. doi: 10.4049/jimmunol.1502220. Epub 2016 Jan 22.

23.

NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective.

Sandanger Ø, Gao E, Ranheim T, Bliksøen M, Kaasbøll OJ, Alfsnes K, Nymo SH, Rashidi A, Ohm IK, Attramadal H, Aukrust P, Vinge LE, Yndestad A.

Biochem Biophys Res Commun. 2016 Jan 22;469(4):1012-20. doi: 10.1016/j.bbrc.2015.12.051. Epub 2015 Dec 17.

PMID:
26706279
24.

Circulating nucleosomes in chronic heart failure.

Nymo SH, Ueland T, Askevold E, Dahl CP, Gullestad L, Aukrust P, Yndestad A.

Int J Cardiol. 2016 Jan 15;203:742-3. doi: 10.1016/j.ijcard.2015.10.219. Epub 2015 Oct 28. No abstract available.

PMID:
26595779
25.

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Askevold ET, Gullestad L, Nymo S, Kjekshus J, Yndestad A, Latini R, Cleland JG, McMurray JJ, Aukrust P, Ueland T.

PLoS One. 2015 Aug 19;10(8):e0133970. doi: 10.1371/journal.pone.0133970. eCollection 2015.

26.

Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure.

Fosshaug LE, Dahl CP, Risnes I, Bohov P, Berge RK, Nymo S, Geiran O, Yndestad A, Gullestad L, Aukrust P, Vinge LE, Øie E.

J Card Fail. 2015 Nov;21(11):916-23. doi: 10.1016/j.cardfail.2015.07.014. Epub 2015 Jul 29.

PMID:
26231517
27.

Complement Activation Correlates With Disease Severity and Contributes to Cytokine Responses in Plasmodium falciparum Malaria.

Berg A, Otterdal K, Patel S, Gonca M, David C, Dalen I, Nymo S, Nilsson M, Nordling S, Magnusson PU, Ueland T, Prato M, Giribaldi G, Mollnes TE, Aukrust P, Langeland N, Nilsson PH.

J Infect Dis. 2015 Dec 1;212(11):1835-40. doi: 10.1093/infdis/jiv283. Epub 2015 May 15.

28.

The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load.

Egge KH, Barratt-Due A, Nymo S, Lindstad JK, Pharo A, Lau C, Espevik T, Thorgersen EB, Mollnes TE.

Clin Exp Immunol. 2015 Sep;181(3):457-67. doi: 10.1111/cei.12645. Epub 2015 Jul 19.

29.

Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial.

Ueland T, Aukrust P, Nymo SH, Kjekshus J, McMurray JJ, Wikstrand J, Block D, Zaugg C, Gullestad L.

J Card Fail. 2015 Feb;21(2):153-9. doi: 10.1016/j.cardfail.2014.10.016. Epub 2014 Nov 7.

PMID:
25451704
30.

The Notch ligand Delta-like 1 is elevated and associated with mortality in patients with symptomatic aortic stenosis.

Abraityte A, Gullestad L, Askevold ET, Nymo S, Dahl CP, Aakhus S, Aukrust P, Ueland T.

Int J Cardiol. 2015 Feb 1;180:18-20. doi: 10.1016/j.ijcard.2014.11.111. Epub 2014 Nov 18. No abstract available.

PMID:
25438200
31.

Predictive value of endostatin in chronic heart failure patients with poor kidney function.

Ueland T, Aukrust P, Nymo SH, Kjekshus J, McMurray JJ, Wikstrand J, Wienhues-Thelen UH, Block D, Zaugg C, Gullestad L.

Cardiology. 2015;130(1):17-22. doi: 10.1159/000368220. Epub 2014 Nov 22.

PMID:
25428583
32.

Inflammatory cytokines as biomarkers in heart failure.

Ueland T, Gullestad L, Nymo SH, Yndestad A, Aukrust P, Askevold ET.

Clin Chim Acta. 2015 Mar 30;443:71-7. doi: 10.1016/j.cca.2014.09.001. Epub 2014 Sep 6. Review.

PMID:
25199849
33.

Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension.

Ohm IK, Gao E, Belland Olsen M, Alfsnes K, Bliksøen M, Øgaard J, Ranheim T, Nymo SH, Holmen YD, Aukrust P, Yndestad A, Vinge LE.

PLoS One. 2014 Aug 15;9(8):e104407. doi: 10.1371/journal.pone.0104407. eCollection 2014.

34.

Cholesterol crystal-induced endothelial cell activation is complement-dependent and mediated by TNF.

Nymo S, Niyonzima N, Espevik T, Mollnes TE.

Immunobiology. 2014 Oct;219(10):786-92. doi: 10.1016/j.imbio.2014.06.006. Epub 2014 Jul 5.

PMID:
25053140
35.

Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.

Samstad EO, Niyonzima N, Nymo S, Aune MH, Ryan L, Bakke SS, Lappegård KT, Brekke OL, Lambris JD, Damås JK, Latz E, Mollnes TE, Espevik T.

J Immunol. 2014 Mar 15;192(6):2837-45. doi: 10.4049/jimmunol.1302484. Epub 2014 Feb 19.

36.

The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure.

Askevold ET, Aukrust P, Nymo SH, Lunde IG, Kaasbøll OJ, Aakhus S, Florholmen G, Ohm IK, Strand ME, Attramadal H, Fiane A, Dahl CP, Finsen AV, Vinge LE, Christensen G, Yndestad A, Gullestad L, Latini R, Masson S, Tavazzi L; GISSI-HF Investigators, Ueland T.

J Intern Med. 2014 Jun;275(6):621-30. doi: 10.1111/joim.12175. Epub 2014 Jan 9.

37.

Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.

Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J; CORONA Study Group.

Circ Heart Fail. 2014 Jan;7(1):96-103. doi: 10.1161/CIRCHEARTFAILURE.113.000450. Epub 2013 Nov 27.

PMID:
24284025
38.

Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.

Nymo SH, Hulthe J, Ueland T, McMurray J, Wikstrand J, Askevold ET, Yndestad A, Gullestad L, Aukrust P.

Eur J Heart Fail. 2014 Jan;16(1):68-75. doi: 10.1093/eurjhf/hft125. Epub 2013 Dec 3.

39.

Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure.

Dahl CP, Aukrust P, Nymo SH, Kjekshus J, Cleland JG, McMurray JJ, Wikstrand J, Gullestad L, Ueland T.

Int J Cardiol. 2013 Oct 9;168(4):4427-9. doi: 10.1016/j.ijcard.2013.05.008. Epub 2013 May 26. No abstract available.

PMID:
23714594
40.

CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.

Ueland T, Nymo SH, Latini R, McMurray JJ, Kjekshus J, Yndestad A, Fucili A, Grosu A, Masson S, Maggioni AP, Gullestad L, Aukrust P; Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) trial; Investigators of the GISSI-Heart Failure (GISSI-HF) trial.

Eur J Heart Fail. 2013 Jul;15(7):747-55. doi: 10.1093/eurjhf/hft031. Epub 2013 Mar 13.

41.

Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Askevold ET, Nymo S, Ueland T, Gravning J, Wergeland R, Kjekshus J, Yndestad A, Cleland JG, McMurray JJ, Aukrust P, Gullestad L.

Circ Heart Fail. 2013 Jan;6(1):91-8. doi: 10.1161/CIRCHEARTFAILURE.112.972653. Epub 2012 Dec 10.

PMID:
23230311
42.

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Aukrust P.

Am Heart J. 2012 Dec;164(6):878-83. doi: 10.1016/j.ahj.2012.08.021. Epub 2012 Oct 29.

PMID:
23194488
43.

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.

Latini R, Gullestad L, Masson S, Nymo SH, Ueland T, Cuccovillo I, Vårdal M, Bottazzi B, Mantovani A, Lucci D, Masuda N, Sudo Y, Wikstrand J, Tognoni G, Aukrust P, Tavazzi L; Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trials.

Eur J Heart Fail. 2012 Sep;14(9):992-9. Epub 2012 Jun 27.

44.

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P; CORONA Study Group.

Eur Heart J. 2012 Sep;33(18):2290-6. Epub 2012 Apr 17.

PMID:
22513778
45.

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.

Broch K, Ueland T, Nymo SH, Kjekshus J, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Cleland JG, Aukrust P, Gullestad L.

Eur J Heart Fail. 2012 Mar;14(3):268-77. doi: 10.1093/eurjhf/hfs006. Epub 2012 Feb 2.

46.

The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.

Nymo SH, Ueland T, Askevold ET, Flo TH, Kjekshus J, Hulthe J, Wikstrand J, McMurray J, Van Veldhuisen DJ, Gullestad L, Aukrust P, Yndestad A.

J Intern Med. 2012 May;271(5):436-43. doi: 10.1111/j.1365-2796.2011.02503.x. Epub 2012 Jan 16.

47.

Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke.

Holm S, Ueland T, Dahl TB, Michelsen AE, Skjelland M, Russell D, Nymo SH, Krohg-Sørensen K, Clausen OP, Atar D, Januzzi JL, Aukrust P, Jensen JK, Halvorsen B.

PLoS One. 2011;6(12):e28785. doi: 10.1371/journal.pone.0028785. Epub 2011 Dec 9.

Supplemental Content

Support Center